AG

Andrew Grupe

CE Celera: 3 patents #31 of 75Top 45%
University of California: 2 patents #4,561 of 18,278Top 25%
QI Quest Diagnostics Investments: 1 patents #174 of 229Top 80%
RA Roche Palo Alto: 1 patents #205 of 347Top 60%
S( Syntex (U.S.A.): 1 patents #356 of 599Top 60%
RS Roche Molecular Systems: 1 patents #392 of 746Top 55%
Genentech: 1 patents #1,597 of 2,392Top 70%
Overall (All Time): #560,535 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11053542 Compositions and methods for screening mutations in thyroid cancer Shih-Min Cheng, Joseph J. CATANESE, Feras Hantash, Frederic Waldman, Kevin Qu 2021-07-06
7816083 Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof Yonghong Li 2010-10-19
7695911 Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof Yonghong Li 2010-04-13
7698117 System and method for predicting chromosomal regions that control phenotypic traits Jonathan Usuka, Gary Peltz 2010-04-13
7651840 Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof Yonghong Li 2010-01-26
6656691 TCF-1 nucleotide sequence variation Ann Begovich, Henry A. Erlich, Janelle A. Noble, Gary Peltz, Rebecca Lynne Reynolds +2 more 2003-12-02
6479490 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3&bgr; Leyi Gong, Gary Peltz 2002-11-12
5968508 Antagonists to insulin receptor tyrosine kinase inhibitor Ira D. Goldfine, Betty A. Maddux, Steven A. Spencer, Timothy Stewart, Denise M. Harrison 1999-10-19
5939269 Antagonists to insulin receptor tyrosine kinase inhibitor Ira D. Goldfine, Betty A. Maddux, Steven A. Spencer, Timothy Stewart 1999-08-17